Literature DB >> 21163448

Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes.

Julian W Sacre1, Bennett Franjic, Christine L Jellis, Carly Jenkins, Jeff S Coombes, Thomas H Marwick.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the independent association between global cardiac autonomic neuropathy (CAN) and left ventricular (LV) dysfunction in addition to regional associations of LV dysinnervation and function, in patients with type 2 diabetes mellitus (T2DM).
BACKGROUND: CAN represents a potential mechanism in the etiology of nonischemic diabetic cardiomyopathy.
METHODS: Clinical measures of CAN based on total spectral power of heart rate variability and cardiac reflex testing and echocardiographic assessment of LV function were performed in 118 patients with type 2 diabetes mellitus. Systolic and diastolic function were defined at rest and peak exercise using peak systolic and peak early diastolic (Em) tissue velocities, calculated in 6 basal- and mid-segments using color tissue Doppler. Iodine 123-metaiodobenzylguanidine imaging was performed in 33 patients to directly quantify global (heart/mediastinum ratio) and regional LV sympathetic integrity.
RESULTS: Patients with CAN demonstrated higher resting heart rate, systolic and mean blood pressures, aortic stiffness, hemoglobin A(1c), and urine albumin/creatinine ratio, in addition to lower peak heart rate, chronotropic index, and exercise capacity. Diastolic function (Em) was associated with CAN, evidenced by total spectral power (r = 0.42, p < 0.001) and heart/mediastinum ratio (r = 0.41, p = 0.017). Diastolic function (Em) at rest and systolic function (peak systolic tissue velocity) at rest and exercise were significantly reduced in patients with CAN. Furthermore, total spectral power was associated with Em independent of age, hypertension, metabolic factors, and other relevant contributors to LV dysfunction (β = 0.20, p = 0.035). Relative regional tracer deficits indicative of local denervation were predominant in the anterior and lateral walls (p < 0.001). Associations with regional Em, independent of global iodine 123-metaiodobenzylguanidine uptake, were identified exclusively in mid-anterior (β = 0.45, p = 0.01) and mid-lateral walls (β = 0.34, p = 0.03). However, no association was found between regional denervation and systolic or diastolic dyssynchrony.
CONCLUSIONS: The diastolic dysfunction of type 2 diabetes mellitus shows associations with both regional markers of sympathetic integrity and clinical markers of autonomic neuropathy.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21163448     DOI: 10.1016/j.jcmg.2010.09.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  42 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.

Authors:  Tatiane M Murça; Tatiane C S Almeida; Mohan K Raizada; Anderson J Ferreira
Journal:  Exp Physiol       Date:  2012-01-27       Impact factor: 2.969

3.  Structural and functional left ventricular impairment in subjects with chronic spinal cord injury and no overt cardiovascular disease.

Authors:  Caterina Driussi; Arianna Ius; Emiliana Bizzarini; Francesco Antonini-Canterin; Antonello d'Andrea; Eduardo Bossone; Olga Vriz
Journal:  J Spinal Cord Med       Date:  2014-01-03       Impact factor: 1.985

Review 4.  Cardiovascular imaging in diabetes mellitus.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

5.  Chronotropic incompetence, echocardiographic abnormalities and exercise intolerance in renal transplant recipients.

Authors:  Maggie Kam Man Ma; Ming Lang Zuo; Desmond Yat Hin Yap; Maggie Ming Yee Mok; Lorraine Pui Yuen Kwan; Gary Chi Wang Chan; David Chung Wah Siu; Tak Mao Chan
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

Review 6.  Current Clinical Applications and Next Steps for Cardiac Innervation Imaging.

Authors:  Mark I Travin
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

7.  Trying to prevent diabetic cardiovascular autonomic neuropathy: more questions than answers.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2014-06-25       Impact factor: 5.952

8.  Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.

Authors:  Jingchuan Guo; Rachel G Miller; Tina Costacou; William P Follansbee; Trevor J Orchard
Journal:  J Diabetes Complications       Date:  2017-12-28       Impact factor: 2.852

9.  The relationship between heart rate variability and left ventricular layer-specific deformation in uncomplicated diabetic patients.

Authors:  Vladan Vukomanovic; Marijana Tadic; Jelena Suzic-Lazic; Vesna Kocijancic; Vera Celic
Journal:  Int J Cardiovasc Imaging       Date:  2016-11-16       Impact factor: 2.357

Review 10.  Echocardiographic feature of diabetic cardiomyopathy: where are we now?

Authors:  Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.